|
2024
|
Invention
|
Humanized muc1 antibody and antibody drug conjugate.
This invention relates to humanized MUC1 an... |
|
|
Invention
|
Humanized muc1 antibody and antibody drug conjugate. This invention relates to humanized MUC1 ant... |
|
|
Invention
|
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug.
The present ... |
|
|
Invention
|
Ophthalmic solution of difluprednate.
The present invention provides a method of treatment of in... |
|
|
Invention
|
Ligand-drug conjugates. The present invention generally relates to Ligand-drug conjugates of the ... |
|
2023
|
Invention
|
Stabilization of phenobarbital sodium for injection.
A lyophilized pharmaceutical composition of... |
|
|
Invention
|
Treatment for parkinson's disease.
The invention relates to a method of treating or preventing P... |
|
|
Invention
|
Methods of treating chronic myeloid leukemia using the tyrosine kinase inhibitor vodobatinib. The... |
|
|
Invention
|
Vodobatinib for reducing progression of parkinson's disease. The present disclosure relates to th... |
|
|
Invention
|
Stabilization of phenobarbital sodium for injection.
The present invention relates to a lyophili... |
|
|
Invention
|
Stabilization of phenobarbital sodium for injection. The present invention relates to a lyophiliz... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neonatal seizures |
|
2022
|
P/S
|
Scientific and technological services, namely, scientific and technological research and design f... |
|
|
Invention
|
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug. The present i... |
|
|
P/S
|
House mark for pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal,... |
|
|
Invention
|
Treatment for parkinson's disease. The invention relates to a method of treating or preventing Pa... |
|
|
P/S
|
Pharmaceutical, phytopharmaceuticals and medicinal preparations for the prevention and/or treatme... |
|
|
P/S
|
Surgical apparatus and instruments for medical, dental and veterinary use; artificial limbs, eyes... |
|
|
P/S
|
Scientific and technological services, namely, research and design in the field of pharmaceutical... |
|
|
P/S
|
Medicinal and pharmaceutical preparations. |
|
|
Invention
|
Method of reducing elevated intraocular pressure.
The present invention relates to a method of r... |
|
|
Invention
|
Method of reducing elevated intraocular pressure. The present invention relates to a method of re... |
|
|
Invention
|
Liposomal composition of a camptothecin derivative. The present invention relates to a liposomal ... |
|
|
Invention
|
Malic enzyme inhibitors.
The present invention relates to novel compounds useful as malic enzyme... |
|
2021
|
Invention
|
Difluprednate for reducing the adverse effects of ocular inflammation.
The present invention pro... |
|
|
Invention
|
Difluprednate for reducing the adverse effects of ocular inflammation. The present invention prov... |
|
|
P/S
|
pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of ophthalmic diseases and disorders |
|
|
P/S
|
medicinal and pharmaceutical preparations for the treatment of neonatal seizures |
|
|
Invention
|
An improved process for the preparation of an aqueous ophthalmic solution of difluprednate.
The ... |
|
|
Invention
|
An improved process for the preparation of an aqueous ophthalmic solution of difluprednate. The p... |
|
|
Invention
|
N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide for treatment of ... |
|
|
Invention
|
N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl) ethynyl]-benzohydrazide for treatment of... |
|
|
Invention
|
Ophthalmic solution of difluprednate. The present invention provides a method of treatment of inf... |
|
|
Invention
|
Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n′-(2-chloro-6-methyl-benzoy... |
|
|
Invention
|
Selective estrogen receptor degrader.
A selective estrogen receptor degrader (SERD), a compound ... |
|
|
Invention
|
Stable multiparticulate pharmaceutical composition of rosuvastatin.
A stable multi-particulate p... |
|
2020
|
Invention
|
Heterocyclic antiestrogens. The present invention provides novel heterocyclic compounds as antica... |
|
|
Invention
|
Malic enzyme inhibitors. The present invention relates to novel compounds useful as malic enzyme ... |
|
|
Invention
|
Cycloalkylidene carboxylic acids and derivatives as btk inhibitors. The present invention relates... |
|
|
Invention
|
Selective estrogen receptor degrader. EHEHH-chromen-7-ol, or pharmaceutically acceptable salts th... |
|
|
Invention
|
Selective estrogen receptor degrader. A selective estrogen receptor degrader (SERD), a compound 3... |
|
|
Invention
|
Camptothecin derivatives.
A compound of Formula I or a pharmaceutically acceptable salt thereof ... |
|
|
Invention
|
Camptothecin derivatives with a disulfide moiety and a piperazine moiety. This invention provides... |
|
|
P/S
|
Ophthalmic preparations |
|
|
Invention
|
Treatment for synucleinopathies.
A method of treating or preventing synucleinopathies in a human... |
|
|
Invention
|
Treatment for synucleinopathies. A method of treating or preventing synucleinopathies in a human ... |
|
2019
|
Invention
|
An injection device.
The present invention relates to an injection device for subcutaneous or in... |
|
|
P/S
|
printed matters, namely, brochures, journals, newsletters, magazines, and pamphlets in the field ... |
|
|
P/S
|
printed matters and publications, namely brochures, newsletters, and pamphlets in the field of ph... |
|
|
P/S
|
scientific and technological services, namely, scientific and technological research and design f... |
|
|
P/S
|
medical services, providing medical information about health issues, medical clinics, medical ass... |
|
|
P/S
|
scientific and technological services, namely research and design for pharmaceuticals, cosmetics,... |
|
|
P/S
|
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmace... |
|
|
P/S
|
Scientific and technological services, namely, scientific research, analysis, and testing in the ... |
|
2018
|
P/S
|
Retail pharmacy services; mail order pharmacy services; pharmaceutical services, namely, processi... |
|
|
Invention
|
Abuse deterrent oral solid dosage form. an outer portion, wherein the portion is devoid of drug s... |
|
|
P/S
|
Pharmaceutical preparations acting on the central nervous system to treat neurological disorders;... |
|
|
Invention
|
Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[n′-(2-chloro-6-methylbenzoyl) hydrazin... |
|
2016
|
P/S
|
Development of Drug Delivery Technology for others for controlled and continuous delivery of drugs |
|
|
P/S
|
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmace... |
|
|
P/S
|
Anti-cancer preparations; Pharmaceutical products for the prevention and treatment of cancer |
|
2015
|
P/S
|
MEDICAL AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT SERVICES, ALL OF THE FOREGOING EXCLUDING SERV... |
|
|
P/S
|
HOUSEMARK FOR MEDICAL SERVICES, HYGIENIC AND BEAUTY CARE FOR HUMAN BEINGS, ALL OF THE FOREGOING E... |
|
|
P/S
|
Health care services, namely, disease management programs; Medical consultations; Providing healt... |
|
|
P/S
|
Medical research; Pharmaceutical research and development; Pharmaceutical research services, all ... |
|
|
P/S
|
Development of new technology for others in the field of pharmaceutical and medicinal formulation... |
|
2012
|
P/S
|
Printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets an... |
